Targeted Resuscitation with TEG & ROTEM

Viscoelastic testing, specifically through thromboelastography (TEG) and rotational thromboelastometry (ROTEM), has transformed how clinicians manage life-threatening bleeding in trauma victims. Unlike traditional lab tests that only analyze isolated blood components, these tools provide a real-time, comprehensive view of how whole blood forms and dissolves clots. By offering immediate data on clotting strength and speed, these technologies allow for precision-guided resuscitations that utilize specific blood products rather than generic protocols. Research indicates that using these methods reduces mortality rates and prevents the unnecessary use of transfusions by accurately identifying coagulation abnormalities. Furthermore, these diagnostics help doctors predict secondary risks, such as excessive clot breakdown or the potential for dangerous blood clots after the initial injury. Ultimately, integrating these advanced monitoring systems into damage control resuscitation is essential for improving survival outcomes in both military and civilian trauma settings. The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. Targeted Resuscitation with TEG & ROTEM Comprehensive Study Guide This study guide provides a comprehensive overview of the role of viscoelastic testing—specifically Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM)—in the identification and management of Trauma-Induced Coagulopathy (TIC). It synthesizes historical context, mechanical principles, clinical applications, and the shift from conventional testing to real-time, whole-blood analysis. Overview of Trauma-Induced Coagulopathy (TIC) Hemorrhage remains the primary cause of death in trauma patients. The "fatal triad" of hypothermia, acidosis, and trauma-induced coagulopathy (TIC) significantly worsens patient outcomes. Historically, clinicians relied on conventional coagulation tests (CCT) to manage these patients, but these methods often prove insufficient in the acute setting. Modern management relies on Damage Control Resuscitation (DCR), a strategy focusing on balanced resuscitation, permissive hypotension, the use of whole blood, and hemostatic adjuncts. Viscoelastic testing is a cornerstone of DCR, providing rapid, real-time data to guide blood product administration. Historical Evolution of Viscoelastic Testing The field of viscoelastic testing has evolved from a research tool to a clinical standard in trauma care: Origins: Hellmut Hartert first described TEG at the University of Heidelberg in 1948.Clinical Integration: It was initially adopted in the 1960s for liver transplantations to identify hyperfibrinolysis and in the 1980s for cardiac surgery to manage anticoagulation and bleeding.Application to Trauma: In 1997, Kaufmann et al. demonstrated the utility of TEG in trauma, showing it could predict transfusion needs and define coagulation abnormalities earlier than other methods.Military and Civilian Expansion: Since 2001, military conflicts have accelerated knowledge regarding the resuscitation of injured soldiers. These advancements have been transferred to civilian trauma centers, leading to the widespread adoption of TEG and ROTEM. Testing Mechanics and Modalities Rotational Thromboelastometry (ROTEM) ROTEM is a point-of-care analyzer that tests the hemostatic profile of whole blood. It functions by placing a blood sample in a cup with an oscillating sensor pin. As a clot forms, it restricts the pin's rotation, and this resistance is converted into a graphical display. ROTEM utilizes five specific assays to evaluate different pathways: INTEM: Uses ellagic acid to activate the intrinsic pathway. It is sensitive to factors I, II, and VII through XII, as well as von Willebrand factor.EXTEM: Uses tissue factor/thromboplastin to activate the extrinsic pathway. It is highly sensitive to fibrinolysis and evaluates factors II, VII, IX, and X.FIBTEM: An EXTEM-based assay that adds cytochalasin D to inhibit platelets. This isolates the role of fibrin polymerization in clot formation.HEPTEM: An INTEM-based assay that adds heparinase to neutralize heparin, allowing for the assessment of the underlying coagulation status in heparinized patients.APTEM: An EXTEM-based assay that adds aprotinin to inhibit fibrinolysis. Comparing APTEM to EXTEM helps confirm true hyperfibrinolysis. Thromboelastography (TEG) TEG uses a similar principle but often involves an oscillating cup and a stationary pin. The standard TEG uses kaolin to activate the coagulation cascade. Rapid TEG (r-TEG): This variant adds tissue factor in addition to kaolin, significantly accelerating the activation process and ...